Sitemap
-
News
-
Press Releases
-
2022 Press Releases
- Cerba Lancet Africa Moving To New Headquarters To Deliver Ambitious Growth Plans For Africa
- Cerba Lancet Africa Signs Strategic Partnership With International Clinical Laboratories in EthiopiaCerba Lancet Africa Signs Strategic Partnership With International Clinical Laboratories in Ethiopia
- Cerba And Taliaz to leverage Artificial Intelligence and Genetics Expertise to improve patient care management in depression
- 2023 Press Releases
-
2022 Press Releases
-
Newsletters
-
2022 Newsletters
- MonkeyPox
- HIV Integrase Inhibitors
- All About HIV
- Diabetes
- BRCA Testing For Hereditary Breast And Ovarian Cancer
- Understand Allergies Better
- Pollen allergy: causes and symptoms
- Detection of New SARS-COVID19 Variants on PCR Testing
- Approach to the Adult Patient with Anaemia
- Cervical Cancer Screening
- Diagnosis of Helicobacter Pylori Infections
- Discrepancy in COVID-19 results explained
- Frequently Asked Questions on COVID-19 Vaccination in Kenya.
- Panorama Prenatal Screen
- Why do you need blood testing
- Antibiotic Guidelines in a Nutshell
- IgM and PCR Co-Testing for COVID-19 at PLKv
- Hepatitis B
- Prostate Specific Antigen
- Cervical Cancer
- Interpretation of COVID-19 RT PCR Positive & Negative Results on Sequential Samples
- Drug Testing
- Approach to Adult Patient with Anemia
- Fatigue and Biological Assessments
- 2023 Newsletters
-
2022 Newsletters
-
In the News
- World-class medical diagnostics for Africa
- Detection of New SARS-COVID19 Variants on PCR Testing
- COVID Press Statement
- Letter from MOH for Covid-19 Testing
- News on Lancet at Goodlife Launch
- MDS Lancet Laboratories Ltd won Customers’ Choice Medical Diagnostic Company Of The Year 2021
- Improving access to quality lab tests among private health care providers in Kenya
- Events
- FAQ
-
Press Releases